OPKO Health Inc. — Director's Dealing 2015

Jun 11, 2015

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response. . . . 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, or Section 30(h) of the Investment Company Act of 1940

| 1. Name and Address of Reporting Person* Baron Robert A | | | 2. Issuer Name and Ticker or Trading Symbol OPKO Health, Inc. (OPK) | | | | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ☑ Director ☐ 10% Owner ☑ Officer (give title below) ☐ Other (specify below) | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | (Last) (First) (Middle) 2401 Ingleside Avenue Suite 1D | | | 3. Date of Earliest Transaction (MM/DD/YYYY) 06/10/2015 | | | | | | | | | (Street) Cincinnati OH 45206 (City) (State) (Zip) | | | 4. If Amendment, Date Original Filed (MM/DD/YYYY) | | | | 6. Individual or Joint/Group Filing (Check Applicable Line) ☑ Form filed by One Reporting Person ☐ Form filed by More than One Reporting Person | | | | | Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | | | | | | | | | | | | 1. Title of Security (Instr 3.) | 2. Transaction Date (MM/DD/YYYY) | 2A. Deemed Execution Date, if any (MM/DD/YYYY) | 3. Transaction Code (Instr. 8) | | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | | | 5. Amount of Securities Beneficially Owned Following Reported Transactions (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | | | | | Code | V | Amount | (A) or (D) | Price | | | | | Common Stock | 06/10/2015 | | P | | 3000 | A | $16.06 | 288965 | D | |

---

FORM 4 (continued)

Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (MM/DD/YYYY)	3A. Deemed Execution Date (MM/DD/YYYY)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (MM/DD/YYYY)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
				Code	V	Amount	(A) or (D)	Exercisable Date	Expiration Date	Title	Amount or Number of Shares

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Adam Logal, Attorney-in-Fact

6/11/2015

**Signature of Reporting Person

Date

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.